How much funding has EQRx raised?

EQRx has raised $700.0M in total funding, most recently a Series B round.

Who are EQRx's investors?

EQRx's investors include Andreessen Horowitz, GV, ARCH Venture Partners.

Where is EQRx headquartered?

EQRx is headquartered in Cambridge, Massachusetts, United States.

What industry is EQRx in?

EQRx operates in Healthcare, Biotech.

EQRx

Closed

Remaking Medicine™

Cambridge, United States · Founded 2019 · $700.0M raised

Healthcare

Biotech

Headquarters: Cambridge, Massachusetts
Employees: 51–200
Founded: 2019
Business Model: B2B

Website: eqrx.com
Total Funding: $700.0M
Last Round: $500.0M Series BJan 2021
Rounds: 2

About

EQRx was a biopharmaceutical company founded in 2019 committed to developing innovative, patent-protected medicines and delivering them at dramatically lower prices than traditional pharmaceutical companies. The company built a pipeline of 10+ programs including Phase 3 oncology assets for non-small cell lung cancer, raised over $750 million in funding, and was acquired by Revolution Medicines in November 2023.

Summary

EQRx is a Healthcare company based in Cambridge, United States, founded in 2019. It has raised $700.0M in total across 2 rounds, most recently a $500.0M Series B round in Jan 2021. Investors include Andreessen Horowitz, GV and ARCH Venture Partners.

LinkedIn X (Twitter)